The modern era of hand transplantation began in 1998 in Lyon, France, where the world’s first successful procedure was performed. In the years that followed, countries such as the United States, China and European nations played important roles in advancing the surgical and immunological foundations of vascularized composite allotransplantation. The longest surviving hand transplant (27 years) is from USA done in 1999 by DR Warren Bridenbachs team. Following this several programs emerged both in USA and Europe supported by research initiatives aimed at restoring limb function in patients with severe injuries.  Following the success of hand transplants other composite tissue transplants namely that of face, uterus, penis and larynx also were initiated in different parts of the globe.

Over the past decade, India has emerged as a global leader in upper-extremity transplantation. The country’s first successful hand transplant was performed in 2015 at Amrita Hospital in Kochi, a major tertiary care university teaching hospital of Amrita Vishwa Vidyapeetham. The surgery was carried out by a multidisciplinary team led by Dr. Subramania Iyer. This historic procedure marked the beginning of vascularized composite allotransplantation in India and demonstrated the advanced surgical capabilities and collaborative clinical expertise available at the institution, while also laying the foundation for academic training, research initiatives, and educational programs in this emerging field.

The center subsequently achieved several global and regional breakthroughs, including Asia’s first double upper-arm (above-elbow) hand transplant in 2017 and the world’s first documented male-to-female hand transplant performed in the same procedure on a young woman who had lost both arms in an accident. These achievements established the Kochi program as one of the leading hand transplant centers in the world.

The legacy of this pioneering program later expanded to North India with the first hand transplant in the region performed at Amrita Hospital, Faridabad, by a team led by Dr. Mohit Sharma who moved over from Kochi to establish the unit when the hospital stared functioning in 2021. This procedure was also the first in the country to be performed on a patient who had previously undergone a kidney transplant. Under the leadership of Dr. Subramania Iyer and Dr. Mohit Sharma, the Amrita program has grown into one of the highest-volume hand transplant programs in the world. The Kochi center alone has performed 17 transplants involving 31 hands, while the combined Amrita program has performed hand transplantation in 23 patients and 40 hands. This has helped India to lead the world now in this field.

The legacy of this pioneering effort has continued to grow across India, with several other centers establishing hand transplant programs. India has ten active centers now, more than any other country in the world.

Each bilateral hand transplant is an extraordinary surgical undertaking. A typical procedure may last between 14 and 17 hours and involves a multidisciplinary team of more than 60 specialists, including plastic surgeons, transplant surgeons, anaesthesiologists, immunologists, physiotherapists, psychiatrists, and specialized nursing teams. For a tertiary care university teaching hospital such as Amrita, pioneering such a program represents far more than a surgical achievement—it marks a major academic and clinical milestone.

Programs like hand transplantation create a powerful platform for advancing medical science. These complex procedures push the boundaries of microsurgery, transplant immunology, nerve regeneration, and rehabilitation science. They also play a crucial role in training the next generation of surgeons, providing residents, fellows, and trainees with exposure to some of the most advanced reconstructive procedures in modern medicine.

Hand transplantation also exemplifies multidisciplinary collaboration, integrating expertise from plastic surgery, transplant medicine, physiotherapy, psychiatry, immunology, and bioethics. Each transplant contributes valuable insights into long-term functional recovery, immunosuppressive strategies, and quality-of-life outcomes, strengthening clinical research and innovation.

In this way, the program enhances Amrita’s role not only as a center for advanced patient care but also as a hub for academic excellence, research, and medical education. Beyond surgical statistics and milestones lies the most important outcome: restoring independence and dignity to patients who have lost their hands. Through years of rehabilitation and support, many recipients regain meaningful sensory and motor function, enabling them to perform daily activities and reintegrate into society. The success of the program reflects the dedication of an entire ecosystem—from surgeons and rehabilitation specialists to organ donors and their families, whose generosity makes such life-changing procedures possible.

Today, global data clearly illustrates a remarkable transformation in the field of hand transplantation. With more than 70 procedures performed nationally and a leading institutional program at Amrita Hospital, India has become a major hub for this advanced reconstructive surgery. As the field continues to evolve, institutions like Amrita are helping redefine what is possible in reconstructive medicine—combining clinical excellence, academic leadership, and compassionate care to push the boundaries of modern surgery.